Related Experiment Video

Updated: Nov 23, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.8K

Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract Cancer

Nduka Ofoeyeno1, Emmanuel Ekpenyong2, Chiara Braconi1,3

  • 1The Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.

Cancers
|December 30, 2020
PubMed

Insights

MicroRNAs (miRNAs) are small non-coding RNAs crucial in biliary tract cancer (BTC) development. Understanding their role offers potential for novel biomarkers and therapies for this challenging disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Biliary tract cancer (BTC) presents a significant clinical challenge due to poor prognosis and limited treatment options.
  • The underlying pathogenesis of BTC is not fully understood, contributing to late diagnoses and therapeutic limitations.

Purpose of the Study:

  • To review the mechanisms of action of non-coding RNAs (ncRNAs).
  • To summarize the specific role of microRNAs (miRNAs) in the progression of biliary tract cancer.
  • To explore the potential of miRNA-based biomarkers and therapeutics for BTC.

Main Methods:

  • Literature review focusing on ncRNA mechanisms.
  • Focused analysis of microRNA roles in BTC pathogenesis and progression.
  • Discussion of current research and future directions for clinical translation.

Main Results:

  • ncRNAs, including miRNAs, play critical roles in cellular processes relevant to oncology.
  • miRNAs have demonstrated significant involvement in the progression of biliary tract cancer.
  • Existing research highlights the potential of miRNAs as diagnostic and therapeutic targets.

Conclusions:

  • miRNAs are key regulators in BTC and represent promising avenues for clinical applications.
  • Further research and technological advancements are necessary to translate miRNA-based strategies into clinical practice for BTC patients.
  • The study underscores the importance of investigating ncRNAs for improving BTC outcomes.
Keywords:
LncRNAbiliary tract cancerbiomarkermiRNAnon-coding RNAtherapy

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.1K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.7K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K